ResQ Pharma, Inc.’s Post

💊 How important is to have effective drugs in chest related urgency scenarios? What role does a fast & accurate treatment play? The answer is shocking: early & accurate response can reduce mortality by 50%! 📉 🌍 We shared this and other data at the HealthVerse Recordati Italia #innovationday organised with PoliHub - Innovation Park & Startup Accelerator, where we stressed the importance of having a fast, differential-diagnostic tool in emergency scenarios for targeted drug delivery. 🚑 This is the mission that Previeni is pursuing with its R&D, and you can learn more by taking a glimpse to our presentation in Italian at the following link (timestamp 1:54.22): https://lnkd.in/dD67MTSK Don't miss also the pitches from the other great projects that presented during the day as the winner MgShell S.r.l., BiomimX® Srl, Moovy(Eleonora Beccaluva), NanoMuG, Avertis (Valentina Lidoni), Eolo, Plasma, EGGS&BEACON. References in the comments area. #startup #startupjobs #prevention #diagnostics #medicalimaging

Attention #biotech innovators and #drug developers ! 📢 Don’t miss the J&J Innovation – #JLABS program on 23 May ! Delve into the transformative world of Target Product Profiles (#TPP) with industry leaders.   Experienced professionals and J&J experts explore : 👉 How do you define the exact target population, #indication and #formulation? 👉 Which benefits, risks and tolerability concerns are acceptable? 👉 What could be unique selling points compared to future competitors? 👉 What is your #businessmodel and who is going to pay, using what model?   Our speakers will discuss how the TPP helps guide prioritization and decision making.   Start-ups, early innovators and #entrepreneurs are welcome to register here: ➡️ https://jji.jnj/43Ss3XD We also welcome stakeholders supporting these #startups.   #jnjinnovation #jjievent #biotechnology #drugdevelopment

Looking forward to the BioTech company presentations and being inspired by the high level of innovation at this level! These conferences are always great for seeing what the future holds for patient populations who still have a high unmet need. Paola Valinotti's advice is just what these assets need to understand what is required to generate a successful outcome, further down the line. And at FINGERPOST, we're happy to bring the research, data, clinical and payer experts together to support Paola and others to deliver this. #marketaccess #pricing #forwardthinking #SwissBiotechDay

👏🏽 Clinical evidence and a clear #regulatory plan as main drivers to #investment - Inaki Berenguer, from LifeX Ventures 👏🏽 Emphasis on the importance of piloting at hospitals before launching a #medtech solution - Ryan Collins, from MassMutual Ventures Great talk about investment drivers, very nicely moderated by - Helena Torras -, from Hans(wo)men Group, today at 4YFN! We’ll take this into account as we raise a 2m round to get The Blue Box Biomedical Solutions through clinical trials, regulatory and launch into the market.

🎉 Congratulations to Kynexis, OrsoBio, and Blackbird Labs! 🎉 Exciting news is making waves in the biotech/pharma industry as these remarkable companies secure massive funding for their groundbreaking projects: 🚀 @Kynexis: Closing their Series A funding round with an impressive $60.9 million investment. This injection of capital will undoubtedly fuel Kynexis' development and drive innovation towards their mission. 🔬 OrsoBio: Celebrating their successful Series A funding, raking in an impressive $60 million. This significant financial boost will accelerate OrsoBio's efforts in revolutionizing the biotech landscape, bringing us closer to groundbreaking solutions. ✨ Blackbird Labs, Inc.: Making headlines with a remarkable $100 million in Series A funding. With this unprecedented investment, Blackbird Labs is poised to shake up the pharma industry and lead the charge in pioneering groundbreaking advancements. We commend these visionary companies for their outstanding achievements, securing substantial funding to propel their respective ventures forward. These investments serve as a testament to the immense potential of biotech and pharma industries in shaping a brighter future. Let's celebrate their accomplishments and eagerly anticipate the remarkable breakthroughs these companies will deliver! #Biotech #Pharma #Innovation #FundingNews #Congrats

📢 High-quality reports, highly efficient process, valuable contacts & successful partnerships. That’s why Dr. Gabriele Schiebel-Schlosser, Global Innovation Management at Schwabe Group, works with 5-HT. 🤩 Meet innovators of 5-HT corporate partners and get inspiration for your open innovation mindset. At 5-HT, we collaborate with great companies like Schwabe & startups who share the same vision about shaping the future of chemistry & healthcare. And it’s about people who work for achieving this mission. “I am always amazed at how many different startup solutions the 𝐡𝐢𝐠𝐡-𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐬𝐜𝐨𝐮𝐭𝐢𝐧𝐠 report from 5-HT can provide us with and the 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭𝐬 that develop from it. The highly efficient and 𝐰𝐞𝐥𝐥 𝐭𝐡𝐨𝐮𝐠𝐡𝐭-𝐨𝐮𝐭 5-𝐇𝐓 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 with individual pitch sessions, alignment and engagement workshops is also impressive and has 𝐛𝐫𝐨𝐮𝐠𝐡𝐭 𝐮𝐬 𝐬𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬”, Gabriele says. Thank you, Gabriele, for driving open innovation with us and for being a committed 5-HT partner 😊 The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All the companies within the Group focus on plants as the basis for developing pharmaceuticals and health products. 👀 Check it out now! www.5-ht.com #5HT_CorporatePartner #5HT_Quote #network #OpenInnovationVoices

🌟 I'm thrilled to congratulate my friends, mentors, and former teammates at Formation Bio on a tremendously successful fundraise! 🌟 "Bring new treatments to patients faster and more efficiently" is an incredibly important mission. It also represents an incredibly long and difficult journey—one that I know Benjamine Liu would emphasize the team is just getting started on, despite how far we've already come! What does one fundraise mean for such a journey? It means well-deserved confidence in the team and its culture to realize the mission. It means realistic optimism for the vision of a world where every disease has a treatment. It means excitement in the potential for innovation at the intersection of AI, tech, and pharma. It means conviction to champion the mission. It's also a recognition of Ben's vision and unwavering resolve -- virtues that influenced me tremendously, as I know they have every Spark. I am immensely proud of this team, and excited to see more and more positive impact on the world through their journey. I'm beyond grateful for the portion of that journey I was able to make with them, and for the personal growth and learning imparted. Here's to the journey ahead, bringing new treatments to patients faster and more efficiently 🚀💡 #Innovation #Healthcare #Funding #AI #Tech #Pharma #ProudMoment

Are you a biotech start-up and do you want to understand regulatory requirements in the biotech industry? 💡 Join our biotech start-up event on 15th November at 17:00, where Cecilie Steglich-Willert will talk about the regulatory framework for biotech start-ups.⚡ 👉Register now to secure your spot: https://lnkd.in/eafZY5CU 👉Event page: https://lnkd.in/eu_kfUZt Disclaimer: Completion of the registration form does not guarantee attendance. All registrations are subject to review to ensure a unified and productive experience for all attendees. You will receive an email confirmation upon approval. We look forward to welcoming you! #Startup #Biotech #Compliance #RegulatoryFramework

Verve Ventures was recently featured among the top techbio and drug discovery investors in Dealroom.co and Speedinvest's TechBio x Drug Discovery report which explores the vast potential of innovation in this field. “We believe that startups embracing the convergence of biology and engineering have the power to shape a future where healthcare is not only more cost-effective but also delivers superior patient outcomes,” says Xavier Mesnier, Principal at Verve. “Through AI-driven patient profiling, platform technologies, and enabling tools, techbio entrepreneurs are catalyzing a paradigm shift in healthcare, where data-driven insights revolutionize how we understand and combat disease." Read the full report: https://lnkd.in/d9BcvV2Q #techbio #drugdiscovery #health #drugdevelopment #futureofhealth #venturecapital

🚀 Today, we have kicked off 10XHEALTH, the new #scaleup program designed to accelerate growth in life science companies in southern Sweden. The one-year program 10XHEALTH is a collaborative effort by SmiLe and Medicon Village, and is tailored to meet the unique needs of innovative scaleups in life science, focusing on areas such as business acumen, financing, internationalization, organization, and effective leadership. While similar programs are well-established in countries like the USA and the UK, they are relatively new in the Swedish context. The ambition behind 10XHEALTH is to expand its reach in the coming years and extend invitations to life science companies from other parts of Sweden. The seven companies from Skåne selected to participate in the pilot starting today are Iconovo AB, Neola Medical, Uman Sense, Paindrainer AB, NanoEcho AB, PILA PHARMA, and Cyxone.   The 10XHEALTH program is partially funded by the European Regional Development Fund. #scaleups #lifescience #accelerator #businessincubator #10XHEALTH